Invention Grant
- Patent Title: Controlled drug release liposome composition
-
Application No.: US14774833Application Date: 2014-03-15
-
Publication No.: US09700511B2Publication Date: 2017-07-11
- Inventor: Pei Kan , Yun-Long Tseng , Han Chun Ou
- Applicant: TAIWAN LIPOSOME COMPANY, LTD , TLC BIOPHARMACEUTICALS, INC.
- Applicant Address: US CA South San Francisco TW Taipei
- Assignee: TLC Biopharmaceuticals, Inc.,Taiwan Liposome Company, Ltd.
- Current Assignee: TLC Biopharmaceuticals, Inc.,Taiwan Liposome Company, Ltd.
- Current Assignee Address: US CA South San Francisco TW Taipei
- Agency: Seed IP Law Group LLP
- International Application: PCT/US2014/029907 WO 20140315
- International Announcement: WO2014/145187 WO 20140918
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/337 ; A61K31/4745 ; A61K31/475 ; A61K31/704 ; A61K31/7048
Abstract:
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.
Public/Granted literature
- US20160030340A1 CONTROLLED DRUG RELEASE LIPOSOME COMPOSITION Public/Granted day:2016-02-04
Information query
